Animal Pharm is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By



Set Alert for Pharmaceuticals

Specialists highlight the underserved areas of microbiome innovation

The microbiome has become an increasingly important topic in animal health. It is especially pertinent in the search for alternative solutions to antibiotics and a more holistic approach to improving and managing animal health. Animal Pharm analyst Sian Lazell found out more at the recent Animal AgTech Innovation Summit in Amsterdam. 

Feed & Additives Pharmaceuticals

Huvepharma broadens scope of Monovet 90 generic with combination approvals

Bulgarian firm Huvepharma has received several combination approvals for its Monovet 90 feed additive in the US. 

Huvepharma Product Approvals

Bayer canine otitis externa treatment get EU positive opinion

European authorities have paved the way for Bayer Animal Health's Neptra Otic Solution canine ear drops to be approved.

Bayer Animal Health Canine

KindredBio set for EU introduction as Mirataz gets positive opinion

Kindred Biosciences has gained an EU positive opinion for its Mirataz therapeutic for weight loss management in cats.

Europe Kindred Biosciences

Amplimune research data highlights financial benefits of scours immunotherapy

Canadian animal health immunobiology firm NovaVive has revealed study data has shown the economic benefits of its immunotherapy for calf scours.

Bovine Pharmaceuticals

Elanco handed supplemental approval for Credelio tablets

Elanco has received a supplemental approval from the US FDA for its Credelio antiparasitic that adds a preventative indication to the product.

Elanco Antiparasitics

Medterra CBD bags NASC approval, enters Baylor R&D pact

US firm Medterra CBD has received an approval for its line of cannabidiol (CBD) products by the National Animal Supplement Council (NASC).

Product Approvals Pharmaceuticals

PharmAust to gain R&D tax rebate for canine cancer trials

Australian oncology firm PharmAust is close to securing an R&D tax rebate for its canine cancer-focused trials.

R&D Pharmaceuticals

Ceva's embattled Velactis receives CVMP negative opinion

European authorities have refused a variation to the terms of the marketing authorization for Ceva Santé Animale's Velactis.

Ceva Sante Animale Pharmaceuticals

FDA supports studies into duration of medically important antimicrobials

The US FDA has awarded $500,000 to research projects aimed at targeting and defining durations of use for certain medically important antimicrobial drugs.

FDA Research

Animal Medicines Australia criticizes government plan to establish APVMA board

Industry body Animal Medicines Australia (AMA) has voiced disapproval of the decision by the country's government to introduce a board to the Australian Pesticides and Veterinary Medicines Authority (APVMA).

Australia Policy & Regulation

BVA calls for removal of no-deal Brexit risk

The British Veterinary Association (BVA) has advocated for a no-deal Brexit to be "taken off the negotiating table" follow analysis of its potential impact on animal health and welfare.

Policy & Regulation Pharmaceuticals
See All